Article By:
ChinaBio® Today
Saturday, May 11, 2024 3:40 PM EDT
Beijing’s Sino Biological completed its $48 million acquisition of Vancouver-based SignalChem Biotech. Additionally, Biocytogen Pharmaceuticals signed a TCR-mimic antibody evaluation and potential licensing agreement with BioCopy AG.
Stock Analysis - Danaher Corp (DHR)
Good analysis on $DHR, thanks.